Skip to content

Comparison of Three Knee Replacements

Functional Outcome of Total Knee Replacement. Randomized Clinical Controlled Trial of Novel and Conventional Implants

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03339557
Enrollment
240
Registered
2017-11-13
Start date
2015-09-01
Completion date
2021-05-31
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty, Osteoarthritis, Knee, Total Knee Replacement

Brief summary

The present randomized controlled trial is designed to compare one novel total knee replacement (TKR) design and two conventional TKR designs in terms of functional outcome. 80 patients will be randomized in each of the three arms (240 altogether).

Detailed description

The study will compare the short-term functional outcome (at 2 years) of TKR performed with a novel TKR design (Persona , Zimmer, Warsaw, IN, USA) against TKRs performed with two conventional designs (PFC, DePuy, Warsaw, IN, USA and Nexgen, Zimmer, Warsaw, IN, USA).

Interventions

DEVICENexGen

Comparing two conventional designs and one novel design

DEVICEPersona

Comparing two conventional designs and one novel design

DEVICEPFC

Comparing two conventional designs and one novel design

Sponsors

Coxa, Hospital for Joint Replacement
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

Patients will be operated upon using the implant allocated in randomization. Participants are blinded to the implant design used for their operation. Staff at the ward is also blinded. And the physiotherapists conducting the follow-up visits (at 2-3 months, 1 year and 2 years, i.e. the outcome assessors) are also blinded to the allocation.

Intervention model description

Patients will be recruited from Coxa outpatient clinic according to inclusion and exclusion criteria. The participating orthopedic surgeons will recruit patients along their out-patient work. The indications for the surgical treatment in the study will follow the routine clinical guidelines of the hospital. When TKR surgery is decided, the eligible patients will be informed and those willing to participate will be randomized into one of the three implant groups.

Eligibility

Sex/Gender
ALL
Age
50 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* patients undergoing total knee replacement surgery for primary osteoarthritis * no previous open major surgery in the joint ( e.g. osteotomy) * unilateral operative treatment, with no plans for surgical treatment of the contralateral knee in the near future * patients living in the local hospital district (Pirkanmaa Hospital District) * Kellgren-Lawrence grade 3-4 knee osteoarthritis in plain radiographs

Exclusion criteria

* Unwilling to provide informed consent * \> 15 degrees varus or valgus, or \>15 degree fixed flexion deformity * predominantly patellofemoral osteoarthritis * Physical, emotional or neurological conditions that would compromise the patient´s compliance with postoperative rehabilitation and follow-up (e.g. drug or alcohol abuse, serious mental illness, general neurological conditions such as Parkinson, MS, etc.)

Design outcomes

Primary

MeasureTime frameDescription
Changes in patient reported outcome measures scores (PROMs), Functional improvementpreoperative, postoperative at 2-3 months, at 1 year and at 2 yearsOxford Knee Score (OKS)

Secondary

MeasureTime frameDescription
Changes in PROMs, Functional improvementpreoperative, postoperative at 2-3 months, at 1 year and at 2 yearsForgotten Joint Score (FJS)
Changes in health-related quality of life (HRQoL)preoperative, postoperative at 2-3 months, at 1 year and at 2 years15D
Changes in activity rating scalepreoperative, postoperative at 2-3 months, at 1 year and at 2 yearsUCLA activity score
Changes in pain scale measurementpreoperative, postoperative at 2-3 months, at 1 year and at 2 yearsVAS pain scale

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026